Literature DB >> 34088771

Comparing Semiquantitative and Qualitative Methods of Vascular 18F-FDG PET Activity Measurement in Large-Vessel Vasculitis.

Himanshu R Dashora1, Joel S Rosenblum1, Kaitlin A Quinn1, Hugh Alessi1, Elaine Novakovich1, Babak Saboury2, Mark A Ahlman2, Peter C Grayson3.   

Abstract

The study rationale was to assess the performance of qualitative and semiquantitative scoring methods for 18F-FDG PET assessment in large-vessel vasculitis.
Methods: Patients with giant cell arteritis or Takayasu arteritis underwent independent clinical and imaging assessments within a prospective observational cohort. 18F-FDG PET/CT scans were interpreted for active vasculitis by central reader assessment. Arterial 18F-FDG uptake was scored by qualitative visual assessment using the PET vascular activity score (PETVAS) and by semiquantitative assessment using SUVs and target-to-background ratios (TBRs) relative to liver or blood activity. The performance of each scoring method was assessed by intrarater reliability using the intraclass correlation coefficient (ICC) and areas under the receiver-operating-characteristic curve, applying physician assessment of clinical disease activity and reader interpretation of vascular PET activity as independent reference standards. The Wilcoxon signed-rank test was used to analyze change in arterial 18F-FDG uptake over time.
Results: Ninety-five patients (giant cell arteritis, 52; Takayasu arteritis, 43) contributed 212 18F-FDG PET studies. The ICC for semiquantitative evaluation (0.99 [range, 0.98-1.00]) was greater than the ICC for qualitative evaluation (0.82 [range, 0.56-0.93]). PETVAS and target-to-background ratio metrics were more strongly associated with reader interpretation of PET activity than SUV metrics. All assessment methods were significantly associated with physician assessment of clinical disease activity, but the semiquantitative metric liver tissue-to-background ratio (TBRLiver) achieved the highest area under the receiver-operating-characteristic curve (0.66). Significant but weak correlations with C-reactive protein were observed for SUV metrics (r = 0.19, P < 0.01) and TBRLiver (r = 0.20, P < 0.01) but not for PETVAS. In response to increased treatment in 56 patients, arterial 18F-FDG uptake was significantly reduced when measured by semiquantitative (TBRLiver, 1.31-1.23; 6.1% change; P < 0.0001) or qualitative (PETVAS, 22-18; P < 0.0001) methods. Semiquantitative metrics provided information complementary to qualitative evaluation in cases of severe vascular inflammation.
Conclusion: Both qualitative and semiquantitative methods of measuring arterial 18F-FDG uptake are useful in assessing and monitoring vascular inflammation in large-vessel vasculitis. Compared with qualitative metrics, semiquantitative methods have superior reliability and better discriminate treatment response in cases of severe inflammation.
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  PET; Takayasu arteritis; giant cell arteritis; outcome measure; vasculitis

Mesh:

Substances:

Year:  2021        PMID: 34088771      PMCID: PMC8805786          DOI: 10.2967/jnumed.121.262326

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  31 in total

1.  The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.

Authors:  Kwang-Hoon Lee; Arthur Cho; Yun-Jung Choi; Sang-Won Lee; You-Jung Ha; Se-Jin Jung; Min-Chan Park; Jong-Doo Lee; Soo-Kon Lee; Yong-Beom Park
Journal:  Arthritis Rheum       Date:  2012-03

2.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

3.  Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients.

Authors:  Fei Kang; Qing Han; Xiang Zhou; Zhaohui Zheng; Shengjun Wang; Wenhui Ma; Kui Zhang; Zhiyong Quan; Weidong Yang; Jing Wang; Ping Zhu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-22       Impact factor: 9.236

4.  Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis.

Authors:  Kaitlin A Quinn; Mark A Ahlman; Ashkan A Malayeri; Jamie Marko; Ali Cahid Civelek; Joel S Rosenblum; Armin A Bagheri; Peter A Merkel; Elaine Novakovich; Peter C Grayson
Journal:  Ann Rheum Dis       Date:  2018-04-17       Impact factor: 19.103

5.  Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis.

Authors:  Peter C Grayson; Gunnar Tomasson; David Cuthbertson; Simon Carette; Gary S Hoffman; Nader A Khalidi; Carol A Langford; Carol A McAlear; Paul A Monach; Philip Seo; Kenneth J Warrington; Steven R Ytterberg; Peter A Merkel
Journal:  J Rheumatol       Date:  2011-12-15       Impact factor: 4.666

Review 6.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Authors:  Hongming Zhuang; Abass Alavi
Journal:  Semin Nucl Med       Date:  2002-01       Impact factor: 4.446

7.  Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Cathy Anne Pinto; Christopher Tong; Ash Rafique; Richard Hargeaves; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

8.  MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis.

Authors:  M Both; K Ahmadi-Simab; M Reuter; O Dourvos; E Fritzer; S Ullrich; W L Gross; M Heller; M Bähre
Journal:  Ann Rheum Dis       Date:  2008-01-26       Impact factor: 19.103

9.  Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

Authors:  Michel Meignan; Andrea Gallamini; Michel Meignan; Andrea Gallamini; Corinne Haioun
Journal:  Leuk Lymphoma       Date:  2009-08

Review 10.  Clinical value of whole-body PET/CT in patients with active rheumatic diseases.

Authors:  Hiroyuki Yamashita; Kazuo Kubota; Akio Mimori
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

View more
  1 in total

1.  Reply: On Semiquantitative Methods for Assessing Vascular 18F-FDG PET Activity in Large-Vessel Vasculitis.

Authors:  Mark A Ahlman; Roberto Maass-Moreno; Peter C Grayson
Journal:  J Nucl Med       Date:  2021-10-28       Impact factor: 10.057

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.